About the project
The main task of the project is to develop a personalized approach for screening and monitoring of the eye complications of diabetes mellitus. This approach would allow us to determine the personalized screening interval for each patient.
The activities of the project will include ophthalmological examination of patients with diabetes, collection of data on the risk factors of DR, automated grading of DR with the use of artificial intelligence, application of machine learning methods for determination of the risk factors for DR and the optimal screening interval and finally, evaluation of the cost-efficacy of the new DR monitoring program.
Oslo University Hospital (OUH) participates, together with UiO, in the management of the project, which is coordinated by the University of Latvia.
PerDiRe started in 2021, and the planned duration for the project is three years.
Long term objectives
To establish a personal medicine and telemedicine system for research and screening in diabetic retinopathy with the use of AI, artificial intelligence.
Financing
Norway has been granted EØS-scolarships for the research program of Baltic Research Programme of the European Economic Area EEA grants; project "Integrated model for personalized diabetic retinopathy screening and monitoring using risk- stratification and automated AI-based fundus image analysis" (PerDiRe)
Coperation
- Dr. Jelizaveta Sokolovska, PhD, University of Latvia, Latvia
- Prof. Rasa Verkauskienė, Lithuanian University of Health Sciences, Lithuania
- Professor Dr Vallo Volke, University of Tartu, Estonia
- Norwegian Association of the Blind
